Skip to main content

Table 2 Microvessel Density counting vs. clinico-pathological features in the complete series (n = 91)

From: Expression of Placenta growth factor (PlGF) in non-Small cell Lung cancer (NSCLC) and the clinical and prognostic significance

Variable

Cases (n and %)

MVD pattern

P value (x2)

  

Low MVD (n =)

High MVD (n =)

 

Sex

    

   Male

63 (69.2%)

37

26

0.654

   Female

28 (30.8%)

15

13

 

Age

    

   ≤60

43 (47.3%)

24

19

0.835

   >60

48 (52.7%)

28

20

 

Histological type

    

   Squamous carcinoma

42 (46.2%)

24

18

0.312

   Adenocarcinoma

33 (36.3%)

20

13

 

   Adenosquamous carcinoma

6 (6.6%)

2

4

 

   Large cell carcinoma

2 (2.2%)

2

0

 

   Carcinoid

2 (2.2%)

0

2

 

   Alveolar carcinoma

6 (6.6%)

4

2

 

Grade of differentiation

    

   Poor

11 (12.1%)

7

4

0.345

   Moderate

48 (52.7%)

24

24

 

   Well

32 (35.2%)

21

11

 

Tumour stage

    

   T1

9 (9.9%)

5

4

0.988

   T2

60 (65.9%)

34

26

 

   T3

19 (20.9%)

11

8

 

   T4

3 (3.3%)

2

1

 

Nodal status

    

   N (-)

49 (53.8%)

29

20

0.678

   N (+)

42 (46.2%)

23

19

 

Vessel cancer embolus

    

   V (-)

67 (73.6%)

39

28

0.812

   V (+)

24 (26.4%)

13

11

 

TNM stage

    

   I

40 (44.0%)

27

13

0.389

   II

20 (22.0%)

10

10

 

   IIIa

28 (30.8%)

14

14

 

   IIIb

1 (1.1%)

0

1

 

   IV

2 (2.2%)

1

1